Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-09-07FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMALOG MIX75/25 (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2007-09-07FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN (insulin lispro) from Eli Lilly and Company. This action updates th…
-
FDA approval · 2007-09-06FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly and Company.
-
FDA approval · 2007-09-06FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro mix 50/50) from Eli Lilly, authorizing the KwikPen deli…
-
FDA approval · 2007-09-06FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG MIX75/25 (insulin lispro) from Eli Lilly and Company. The action involves an additional …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-08-22FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly and Company (including the associated diluent).
-
FDA approval · 2007-08-22FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN 70/30 (insulin human) from Eli Lilly and Company.
-
FDA approval · 2007-08-22FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly. The approval covers changes under a supplemental submi…
-
FDA approval · 2007-08-22FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro) from Eli Lilly and Company to update the product's lab…
-
CLINICAL_TRIALS trial_result · 2007-07-12Clinical Trial Update: Investigation of Correlation Between Concentrations of Glucose in Blood and Interstitial Fluid in Type 1 Diabetics
Completed clinical trial evaluating the relationship between blood glucose and interstitial glucose concentrations in individuals with Type …
-
CLINICAL_TRIALS research · 2007-06-26Clinical Trial Update: The Role of Physical Activity in the Treatment of Children With Type 1 Diabetes. [NA]
An update on a clinical trial evaluating the role of physical activity in the treatment of children with Type 1 diabetes.
-
FDA approval · 2007-06-14FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2007-05-21Clinical Trial Update: Impact of Optimized Titration and Delivery of Bedtime Insulin on Prevention of Nocturnal Hypoglycemia [NA]
This clinical trial update examines how optimized titration and delivery of bedtime insulin might prevent nocturnal hypoglycemia. The study …
-
FDA approval · 2007-05-16FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
FDA approves a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2007-05-14Clinical Trial Update: Do Sulphonylureas Preserve Cortical Function During Hypoglycaemia? [Phase 4]
A Phase 4 clinical trial update exploring whether sulphonylurea therapy preserves cortical function during hypoglycaemia in patients with Ty…
-
FDA approval · 2007-04-25FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for LANTUS SOLOSTAR (insulin glargine) from Sanofi-aventis U.S. LLC.
-
CLINICAL_TRIALS research · 2007-04-25Clinical Trial Update: Autologous Bone Marrow Mononuclear Cells Transplantation in Treating Diabetes Patients [Phase 1, Phase 2]
A phase 1/2 trial update on autologous bone marrow mononuclear cells transplantation for type 1 and type 2 diabetes; current status is UNKNO…
-
CLINICAL_TRIALS trial_result · 2007-04-19Clinical Trial Update: Comparison Between Insulin Pump Treatment and Multiple Daily Insulin Injections in Diabetic Type 1 Children [Phase 4]
Phase 4 trial comparing insulin pump therapy to multiple daily insulin injections in children with type 1 diabetes.
-
CLINICAL_TRIALS trial_result · 2007-04-05Clinical Trial Update: Ischemic Injury and Ischemic Preconditioning in Diabetes
This completed clinical trial update investigates ischemic injury and ischemic preconditioning in individuals with insulin-dependent diabete…
-
CLINICAL_TRIALS trial_result · 2007-03-01Clinical Trial Update: Monocyte Function and Inflammation in Type 1 Diabetes and Its Modulation [Phase 2]
This Phase 2 trial studied modulation of monocyte function and inflammation in Type 1 diabetes mellitus and has completed.
-
CLINICAL_TRIALS trial_result · 2007-02-15Clinical Trial Update: Severe Hypoglycemia in Pregnant Women With Type 1 Diabetes
A completed clinical trial investigating severe hypoglycemia in pregnant women with Type 1 diabetes; sponsored by Rigshospitalet, Denmark.
-
CLINICAL_TRIALS trial_result · 2007-02-13Clinical Trial Update: Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus. [Phase 3]
A six-month Phase 3 trial evaluating the efficacy and safety of inhaled insulin in Type 1 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2007-02-13Clinical Trial Update: Six Month Clinical Trial Assessing Efficacy and Safety of Inhaled Insulin in Type 1 Diabetes [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of inhaled insulin in Type 1 diabetes has completed.
-
FDA label_change · 2007-01-26FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NovoLOG (insulin aspart) submitted by Novo Nordisk, updating the product labeling.
-
CLINICAL_TRIALS research · 2007-01-09Clinical Trial Update: Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 Diabetes [NA]
A clinical trial is evaluating polyclonal anti-T-lymphocyte globulin (ATG) in individuals with Type 1 diabetes, but the current trial status…